Event Information

ChinaBio Partnering Forum 2012

Kempinski Hotel Suzhou
1 Guobin Road
Suzhou Industrial Park
Suzhou, Jiangsu 215021 China

Cooley partners Lila Hope and Nan Wu will be speaking at this event.

Cooley is sponsoring a special half-day Partnering Bootcamp that will help entrepreneurs and scientists launching their life science business in China with strategic advice and practical tips to protect their intellectual property positions and develop partnerships with international pharma.

Panel Time - 13:45–15:00

Launching any business, but especially a life science business in China, can be very challenging. Industry experts describe strategies on licensing and partnering and creating IP protection, all designed to maximize your business's potential for success.

Topics include:

  • From the first in-license at a company's formation to partnering pipeline products: key considerations and strategies
  • IP: Building patent and exclusivity positions to become "must have" partners


  • Lila Hope, PhD, JD – Partner, Cooley LLP, Palo Alto/Shanghai
  • Nan Wu, MD, PhD, JD – Partner, Cooley LLP, San Francisco/San Diego/Shanghai

Panel time - 15:30–16:30

Whether it's licensing, co-development, distribution or a broad collaboration, establishing a partnering relationship will be one of the most important steps your company takes. This session will cover what you should be looking for in a partner, and what partners are looking for in you.


  • Greg B. Scott – President and Founder, ChinaBio® LLC
  • Jimmy Z. Zhang, PhD, MBA – Greater China Lead, Licensing, Acquisitions & External Research, Worldwide Licensing & Acquisitions, Merck & Co., Inc.
  • Lila Hope, PhD, JD – Partner, Cooley LLP, Palo Alto/Shanghai

For more information or to register, please visit the event website.

Related Attorneys

Related Practices

Related Offices

©2003-2016 Cooley LLP and Cooley (UK) LLP. All rights reserved.
COOLEY® and the COOLEY LLP® logo are registered U.S. service marks of Cooley LLP.
Cooley was founded in 1920 – for our story, visit our timeline.